Market opportunities in the Pulmonary Arterial Hypertension (PAH) sector include increased demand for innovative therapies ...
Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...
Pulmonary arterial hypertension (PAH) is a rare and progressive condition caused by high blood pressure in the arteries that ...
Using nationwide networks, advanced cytokine profiling, and patient clustering, the team screened over 100 PAH patients to ...
Gothenburg, Sweden Tuesday, November 11, 2025, 15:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback